Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1988 Jul 16;297(6642):185–187. doi: 10.1136/bmj.297.6642.185

Infection control revisited: dilemma facing today's bronchoscopists.

P J Hanson 1, D J Jeffries 1, J C Batten 1, J V Collins 1
PMCID: PMC1834244  PMID: 3408959

Abstract

The emergence of the acquired immune deficiency syndrome has provoked a widespread review of policies for infection control. Incomplete knowledge about the human immunodeficiency virus (HIV), hepatitis B virus, and mycobacteria has until now been compensated for by adopting "overkill" precautions for patients who were thought to harbour these organisms. This policy is no longer tenable, given the difficulty in identifying infected patients. The control of infection in hospitals must instead be based on the routine use of high standards of hygiene that are adequate to contain all pathogens. Attempts by bronchoscopists to formulate such a policy have been frustrated by the lack of a suitable disinfectant and by ignorance of the susceptibility of microorganisms to cleaning and disinfection in a clinical environment.

Full text

PDF
185

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Babb J. R., Bradley C. R. Decontamination of fibrescopes--recent developments. J Sterile Serv Manage. 1984 Oct;2(3):8–10. [PubMed] [Google Scholar]
  2. Bageant R. A., Marsik F. J., Kellogg V. A., Hyler D. L., Gröschel D. H. In-use testing of four glutaraldehyde disinfectants in the Cidematic washer. Respir Care. 1981 Dec;26(12):1255–1261. [PubMed] [Google Scholar]
  3. Birnie G. G., Quigley E. M., Clements G. B., Follet E. A., Watkinson G. Endoscopic transmission of hepatitis B virus. Gut. 1983 Feb;24(2):171–174. doi: 10.1136/gut.24.2.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bond W. W., Favero M. S., Petersen N. J., Ebert J. W. Inactivation of hepatitis B virus by intermediate-to-high-level disinfectant chemicals. J Clin Microbiol. 1983 Sep;18(3):535–538. doi: 10.1128/jcm.18.3.535-538.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chayt K. J., Harper M. E., Marselle L. M., Lewin E. B., Rose R. M., Oleske J. M., Epstein L. G., Wong-Staal F., Gallo R. C. Detection of HTLV-III RNA in lungs of patients with AIDS and pulmonary involvement. JAMA. 1986 Nov 7;256(17):2356–2359. [PubMed] [Google Scholar]
  6. Dawson D. J., Armstrong J. G., Blacklock Z. M. Mycobacterial cross-contamination of bronchoscopy specimens. Am Rev Respir Dis. 1982 Dec;126(6):1095–1097. doi: 10.1164/arrd.1982.126.6.1095. [DOI] [PubMed] [Google Scholar]
  7. Leers W. D. Disinfecting endoscopes: how not to transmit Mycobacterium tuberculosis by bronchoscopy. Can Med Assoc J. 1980 Aug 23;123(4):275-80, 283. [PMC free article] [PubMed] [Google Scholar]
  8. Martin L. S., McDougal J. S., Loskoski S. L. Disinfection and inactivation of the human T lymphotropic virus type III/Lymphadenopathy-associated virus. J Infect Dis. 1985 Aug;152(2):400–403. doi: 10.1093/infdis/152.2.400. [DOI] [PubMed] [Google Scholar]
  9. Nelson K. E., Larson P. A., Schraufnagel D. E., Jackson J. Transmission of tuberculosis by flexible fiberbronchoscopes. Am Rev Respir Dis. 1983 Jan;127(1):97–100. doi: 10.1164/arrd.1983.127.1.97. [DOI] [PubMed] [Google Scholar]
  11. Pappas S. A., Schaaff D. M., DiCostanzo M. B., King F. W., Jr, Sharp J. T. Contamination of flexible fiberoptic bronchoscopes. Am Rev Respir Dis. 1983 Mar;127(3):391–392. doi: 10.1164/arrd.1983.127.3.391a. [DOI] [PubMed] [Google Scholar]
  12. Quinnan G. V., Jr, Wells M. A., Wittek A. E., Phelan M. A., Mayner R. E., Feinstone S., Purcell R. H., Epstein J. S. Inactivation of human T-cell lymphotropic virus, type III by heat, chemicals, and irradiation. Transfusion. 1986 Sep-Oct;26(5):481–483. doi: 10.1046/j.1537-2995.1986.26587020131.x. [DOI] [PubMed] [Google Scholar]
  13. Resnick L., Pitchenik A. E., Fisher E., Croney R. Detection of HTLV-III/LAV-specific IgG and antigen in bronchoalveolar lavage fluid from two patients with lymphocytic interstitial pneumonitis associated with AIDS-related complex. Am J Med. 1987 Mar;82(3):553–556. doi: 10.1016/0002-9343(87)90461-x. [DOI] [PubMed] [Google Scholar]
  14. Resnick L., Veren K., Salahuddin S. Z., Tondreau S., Markham P. D. Stability and inactivation of HTLV-III/LAV under clinical and laboratory environments. JAMA. 1986 Apr 11;255(14):1887–1891. [PubMed] [Google Scholar]
  15. Salahuddin S. Z., Rose R. M., Groopman J. E., Markham P. D., Gallo R. C. Human T lymphotropic virus type III infection of human alveolar macrophages. Blood. 1986 Jul;68(1):281–284. [PubMed] [Google Scholar]
  16. Siegman-Igra Y., Inbar G., Campus A. An 'outbreak' of pulmonary pseudoinfection by Serratia marcescens. J Hosp Infect. 1985 Jun;6(2):218–220. doi: 10.1016/s0195-6701(85)80101-8. [DOI] [PubMed] [Google Scholar]
  17. Spire B., Barré-Sinoussi F., Montagnier L., Chermann J. C. Inactivation of lymphadenopathy associated virus by chemical disinfectants. Lancet. 1984 Oct 20;2(8408):899–901. doi: 10.1016/s0140-6736(84)90657-3. [DOI] [PubMed] [Google Scholar]
  18. Ziza J. M., Brun-Vezinet F., Venet A., Rouzioux C. H., Traversat J., Israel-Biet B., Barre-Sinoussi F., Chermann J. C., Godeau P. Lymphadenopathy-associated virus isolated from bronchoalveolar lavage fluid in AIDS-related complex with lymphoid interstitial pneumonitis. N Engl J Med. 1985 Jul 18;313(3):183–183. doi: 10.1056/NEJM198507183130313. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES